VTE risk factors
| Acute illness . | Clinical . | Genetic . |
|---|---|---|
| Acute MI | Age > 60 y | Antithrombin deficiency |
| Acute heart failure (NYHA class III or IV) | History of VTE | Protein C deficiency |
| Acute infectious disease | History of malignancy | Protein S deficiency |
| Acute respiratory disease | Known thrombophilia | Hyperhomocysteinemia |
| Acute rheumatic disease | Extreme limitation in mobility | Raised prothrombin levels |
| Autoimmune diseases | Estrogen therapy or pregnancy | Factor V Leiden |
| Ischemic stroke | Obesity | Raised factor VIII levels |
| Thrombocytosis | Hyperfibrinogenemia | |
| Varicose veins | ||
| Chronic kidney disease or nephrotic syndrome |
| Acute illness . | Clinical . | Genetic . |
|---|---|---|
| Acute MI | Age > 60 y | Antithrombin deficiency |
| Acute heart failure (NYHA class III or IV) | History of VTE | Protein C deficiency |
| Acute infectious disease | History of malignancy | Protein S deficiency |
| Acute respiratory disease | Known thrombophilia | Hyperhomocysteinemia |
| Acute rheumatic disease | Extreme limitation in mobility | Raised prothrombin levels |
| Autoimmune diseases | Estrogen therapy or pregnancy | Factor V Leiden |
| Ischemic stroke | Obesity | Raised factor VIII levels |
| Thrombocytosis | Hyperfibrinogenemia | |
| Varicose veins | ||
| Chronic kidney disease or nephrotic syndrome |
NYHA indicates New York Heart Association.